{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:00:11Z","timestamp":1780059611663,"version":"3.54.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,4]]},"DOI":"10.7759\/cureus.106430","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:10:49Z","timestamp":1775322649000},"source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous Small Vessel Vasculitis Secondary to Clozapine Use in a 22-Year-Old Man With Treatment-Resistant Schizophrenia"],"prefix":"10.7759","author":[{"given":"Kumaran O","family":"Ravindran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Kapil V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaswamy","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindran O","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane J","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988, 45:789-96. 10.1001\/archpsyc.1988.01800330013001","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia--the role of clozapine","volume":"14","author":"Meltzer HY","year":"1997","unstructured":"Meltzer HY. Treatment-resistant schizophrenia--the role of clozapine. Curr Med Res Opin. 1997, 14:1-20. 10.1185\/03007999709113338","journal-title":"Curr Med Res Opin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.","volume":"382","author":"Leucht S","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, et al.. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.. Lancet. 2013, 382:951-62. 10.1016\/S0140-6736(13)60733-3","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re H","year":"2006","unstructured":"Peyri\u00e8re H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2006, 155:422-8. 10.1111\/j.1365-2133.2006.07284.x","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000181109.54532.c5","article-title":"Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis","volume":"27","author":"Carlson JA","year":"2005","unstructured":"Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005, 27:504-28. 10.1097\/01.dad.0000181109.54532.c5","journal-title":"Am J Dermatopathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500277971","article-title":"Management of leukocytoclastic vasculitis","volume":"16","author":"Sunderk\u00f6tter C","year":"2005","unstructured":"Sunderk\u00f6tter C, Bonsmann G, Sindrilaru A, Luger T. Management of leukocytoclastic vasculitis. J Dermatolog Treat. 2005, 16:193-206. 10.1080\/09546630500277971","journal-title":"J Dermatolog Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen KR","year":"2008","unstructured":"Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008, 9:71-92. 10.2165\/00128071-200809020-00001","journal-title":"Am J Clin Dermatol"},{"key":"ref9","article-title":"Leukocytoclastic vasculitis","author":"Baigrie D","year":"2026","unstructured":"Baigrie D, Crane JS. Leukocytoclastic vasculitis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0545-9","article-title":"Drug-induced vasculitis: new insights and a changing lineup of suspects","volume":"17","author":"Grau RG","year":"2015","unstructured":"Grau RG. Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep. 2015, 17:71. 10.1007\/s11926-015-0545-9","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2015.0043","article-title":"Updates in ANCA-associated vasculitis","volume":"3","author":"Pagnoux C","year":"2016","unstructured":"Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol. 2016, 3:122-33. 10.5152\/eurjrheum.2015.0043","journal-title":"Eur J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2017.45","article-title":"A clozapine-induced hypersensitivity reaction","volume":"37","author":"Curtis L","year":"2020","unstructured":"Curtis L, Hallahan B, Byrne F. A clozapine-induced hypersensitivity reaction. Ir J Psychol Med. 2020, 37:122-5. 10.1017\/ipm.2017.45","journal-title":"Ir J Psychol Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_384_18","article-title":"Leukocytoclastic vasculitis secondary to clozapine","volume":"61","author":"Mukherjee S","year":"2019","unstructured":"Mukherjee S, Era N, Mukherjee M, Tripathi SK. Leukocytoclastic vasculitis secondary to clozapine. Indian J Psychiatry. 2019, 61:94-6. 10.4103\/psychiatry.IndianJPsychiatry_384_18","journal-title":"Indian J Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2019.1628413","article-title":"Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report","volume":"4","author":"Fujimoto S","year":"2020","unstructured":"Fujimoto S, Ueda N, Nishimura N, et al.. Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report. Mod Rheumatol Case Rep. 2020, 4:70-3. 10.1080\/24725625.2019.1628413","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463013-cutaneous-small-vessel-vasculitis-secondary-to-clozapine-use-in-a-22-year-old-man-with-treatment-resistant-schizophrenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:10:49Z","timestamp":1775322649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463013-cutaneous-small-vessel-vasculitis-secondary-to-clozapine-use-in-a-22-year-old-man-with-treatment-resistant-schizophrenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.106430","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,4]]}}}